Login / Signup

Editorial: changes in renal function and bone mineral density after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in chronic hepatitis B patients-author's reply.

Georgios Papatheodoridis
Published in: Alimentary pharmacology & therapeutics (2022)
Keyphrases
  • bone mineral density
  • end stage renal disease
  • postmenopausal women
  • body composition
  • ejection fraction
  • chronic kidney disease
  • hepatitis b virus
  • peritoneal dialysis
  • prognostic factors